Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders

It is estimated that 20–67% of those with COVID-19 develop olfactory disorders, depending on the SARS-CoV-2 variant. However, there is an absence of quick, population-wide olfactory tests to screen for olfactory disorders. The purpose of this study was to provide a proof-of-concept that SCENTinel 1....

Descripción completa

Detalles Bibliográficos
Autores principales: Hunter, Stephanie R., Hannum, Mackenzie E., Pellegrino, Robert, O’Leary, Maureen A., Rawson, Nancy E., Reed, Danielle R., Dalton, Pamela H., Parma, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963695/
https://www.ncbi.nlm.nih.gov/pubmed/35350197
http://dx.doi.org/10.1101/2022.03.23.22272807

Ejemplares similares

Ejemplares similares